NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $820,244 | – | 1,376,249 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monaco Asset Management SAM | 4,809,601 | $2,864,598 | 0.85% |
| Lynx1 Capital Management LP | 1,766,815 | $1,052,315 | 0.70% |
| CM Management, LLC | 800,000 | $476,480 | 0.51% |
| Deep Track Capital, LP | 18,400,000 | $10,959,040 | 0.42% |
| TANG CAPITAL MANAGEMENT LLC | 3,939,600 | $2,346,426 | 0.33% |
| Acuitas Investments, LLC | 721,460 | $429,702 | 0.25% |
| RA Capital Management | 18,700,000 | $11,137,720 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 1,841,078 | $1,097 | 0.09% |
| UBS OCONNOR LLC | 1,376,249 | $820,244 | 0.02% |
| Marquette Asset Management, LLC | 148,378 | $88,374 | 0.02% |